Preprint: Just three mutations for SARS-CoV-2 to escape from highly neutralizing convalescent plasma
“Only three mutations were sufficient to generate this escape variant.” This work shows that, under strong immune pressure, SARS-CoV-2 can use mutations in both the N-terminal domain and the receptor-binding domain to escape potent polyclonal neutralizing responses. Indeed, after a long period under immune selective pressure, SARS-CoV-2 evolved to evade the immunity of a potent polyclonal serum from a COVID-19 convalescent donor. Only three mutations were sufficient to generate this escape variant. The new virus was resistant to 70% of the neutralizing antibodies tested and had a decreased susceptibility to all convalescent sera.
Preprint: SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
** This post was originally published on August 23, 2021 **